ECS Botanics Financials
ECS Stock | 0.02 0 6.25% |
ECS | Select Account or Indicator |
Understanding current and past ECS Botanics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ECS Botanics' financial statements are interrelated, with each one affecting the others. For example, an increase in ECS Botanics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in ECS Botanics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ECS Botanics Holdings. Check ECS Botanics' Beneish M Score to see the likelihood of ECS Botanics' management manipulating its earnings.
ECS Botanics Stock Summary
ECS Botanics competes with Aneka Tambang, Commonwealth Bank, Commonwealth Bank, Australia, and ANZ Group. ECS Botanics is entity of Australia. It is traded as Stock on AU exchange.Foreign Associate | Canada |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | Australia Stock View All |
Exchange | Australian Securities Exchange |
ISIN | AU0000052490 |
Business Address | 899 River Road, |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.ecs-botanics.com |
Phone | 61 13 0016 9775 |
You should never invest in ECS Botanics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ECS Stock, because this is throwing your money away. Analyzing the key information contained in ECS Botanics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ECS Botanics Key Financial Ratios
ECS Botanics' financial ratios allow both analysts and investors to convert raw data from ECS Botanics' financial statements into concise, actionable information that can be used to evaluate the performance of ECS Botanics over time and compare it to other companies across industries.Revenue | 20.03 M | ||||
Gross Profit | 5.31 M | ||||
EBITDA | 3.24 M | ||||
Net Income | 1.92 M | ||||
Cash And Equivalents | 1.87 M |
ECS Botanics Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 20.0M | 23.8M | 26.1M | 32.9M | 37.8M | 39.7M | |
Other Current Liab | 2.1M | 407.5K | 689.8K | 1.5M | 1.7M | 1.8M | |
Net Debt | (4.2M) | (1.8M) | (2.2M) | (2.1M) | (2.5M) | (2.3M) | |
Retained Earnings | (9.8M) | (10.9M) | (10.9M) | (8.7M) | (7.9M) | (8.3M) | |
Cash | 4.2M | 1.9M | 2.5M | 3.2M | 3.6M | 2.3M | |
Net Receivables | 427.1K | 2.2M | 2.5M | 1.8M | 2.1M | 1.3M | |
Total Liab | 2.9M | 1.7M | 3.9M | 4.7M | 5.4M | 5.4M | |
Total Current Assets | 8.0M | 14.9M | 14.1M | 19.7M | 22.6M | 23.8M | |
Short Term Debt | 8.6K | (393.2K) | (709.0K) | 238.7K | 214.8K | 342.2K | |
Common Stock | 10.2M | 24.9M | 32.8M | 36.5M | 42.0M | 30.7M | |
Accounts Payable | 615.1K | 703.5K | 1.7M | 2.2M | 2.5M | 2.1M | |
Inventory | 3.0M | 6.1M | 8.0M | 13.0M | 14.9M | 15.7M | |
Other Current Assets | 397.4K | 4.7M | 1.1M | 1.8M | 2.0M | 2.1M | |
Net Invested Capital | 17.1M | 22.4M | 22.2M | 28.2M | 32.4M | 34.1M | |
Net Working Capital | 6.6M | 13.3M | 10.5M | 15.8M | 18.2M | 19.1M | |
Net Tangible Assets | 5.0M | 14.2M | 18.5M | 18.6M | 21.4M | 12.6M | |
Capital Stock | 10.2M | 24.9M | 32.8M | 36.5M | 32.9M | 25.2M |
ECS Botanics Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 253.9K | 3.9K | 40.5K | 61.8K | 71.0K | 67.5K | |
Operating Income | (5.5M) | (1.8M) | (3.0M) | 1.4M | 1.3M | 1.4M | |
Ebitda | (4.7M) | (59.3K) | 1.6M | 3.2M | 3.7M | 3.9M | |
Income Before Tax | (4.9M) | 174.4K | 491.4K | 1.8M | 1.7M | 1.7M | |
Net Income | (4.3M) | (1.1M) | 228.4K | 1.9M | 1.7M | 1.8M | |
Income Tax Expense | (753.7K) | 8.2K | 263.0K | (70.4K) | (80.9K) | (85.0K) | |
Total Revenue | 1.2M | 5.3M | 15.4M | 20.0M | 23.0M | 14.5M | |
Gross Profit | (3.6M) | 120.3K | (1.1M) | 7.5M | 6.8M | 3.9M | |
Ebit | (4.9M) | (721.7K) | 507.7K | 1.9M | 2.2M | 2.3M | |
Cost Of Revenue | 4.8M | 5.2M | 16.5M | 12.5M | 14.4M | 10.2M | |
Interest Income | 875.0 | 617.0 | 40.5K | 35.4K | 40.7K | 20.5K |
ECS Botanics Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Other Non Cash Items | 437.4K | (2.1M) | (1.5M) | 20.7K | 18.6K | 17.7K | |
Capital Expenditures | 3.4M | 2.9M | 3.3M | 2.4M | 2.8M | 2.9M | |
Net Income | (4.3M) | 166.2K | 491.4K | 1.9M | 1.7M | 1.8M | |
End Period Cash Flow | 4.2M | 1.9M | 2.5M | 3.2M | 3.6M | 2.2M | |
Change In Cash | 2.3M | (2.4M) | 676.1K | 615.2K | 707.5K | 742.9K | |
Free Cash Flow | (5.7M) | (7.6M) | (2.9M) | (3.9M) | (3.5M) | (3.3M) | |
Depreciation | 187.9K | 662.4K | 1.0M | 1.3M | 1.5M | 1.6M | |
Investments | (4.6M) | (3.9M) | (37.4K) | (2.4M) | (2.2M) | (2.3M) | |
Change To Inventory | 104.8K | (28.9K) | 648.0K | (5.1M) | (4.6M) | (4.4M) | |
Change To Netincome | 2.6M | 875.6K | (948.2K) | (2.4M) | (2.1M) | (2.0M) |
ECS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ECS Botanics's current stock value. Our valuation model uses many indicators to compare ECS Botanics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ECS Botanics competition to find correlations between indicators driving ECS Botanics's intrinsic value. More Info.ECS Botanics Holdings is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ECS Botanics Holdings is roughly 1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ECS Botanics' earnings, one of the primary drivers of an investment's value.ECS Botanics Holdings Systematic Risk
ECS Botanics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ECS Botanics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on ECS Botanics Holdings correlated with the market. If Beta is less than 0 ECS Botanics generally moves in the opposite direction as compared to the market. If ECS Botanics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ECS Botanics Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ECS Botanics is generally in the same direction as the market. If Beta > 1 ECS Botanics moves generally in the same direction as, but more than the movement of the benchmark.
ECS Botanics Holdings Total Assets Over Time
ECS Botanics January 3, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ECS Botanics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ECS Botanics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of ECS Botanics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing ECS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ECS Botanics's daily price indicators and compare them against related drivers.
Downside Deviation | 6.03 | |||
Information Ratio | 0.0019 | |||
Maximum Drawdown | 20.53 | |||
Value At Risk | (6.25) | |||
Potential Upside | 6.25 |
Additional Tools for ECS Stock Analysis
When running ECS Botanics' price analysis, check to measure ECS Botanics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECS Botanics is operating at the current time. Most of ECS Botanics' value examination focuses on studying past and present price action to predict the probability of ECS Botanics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ECS Botanics' price. Additionally, you may evaluate how the addition of ECS Botanics to your portfolios can decrease your overall portfolio volatility.